Effects of intensity and type of prepulse stimulus on prepulse inhibition in scopolamine treated rats

Pharmacology Biochemistry and Behavior

Volumn 87, Issue 4, 2007, Pages 481-488

  Andrus, Amanda K ^a,b   Marable, Brian R ^a   Dunbar, Gary L ^b   Reilly, Mark P ^b   Maurissen, Jacques P J ^a,b  

^a DOW CHEMICAL COMPANY   (United States)

^b CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

Frequency; Parameters; Prepulse inhibition; Prepulse reactivity; Scopolamine; Stimulus intensity

Indexed keywords

SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; MALE; MEASUREMENT; NOISE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STARTLE REFLEX; WHITE NOISE;

ACOUSTIC STIMULATION; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCARINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE; STARTLE REACTION;

RATTUS;

EID: 34547736065     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.06.004     Document Type: Article

References (23)

1. Acocella C.M., and Blumenthal T.D. Directed attention influences the modification of startle reflex probability. Psychol Rep 66 (1990) 275-285
2. Adams J., Buelke-Sam J., Kimmel C.A., Nelson C.J., Reiter L.W., Sobotka T.J., et al. Collaborative behavioral teratology study: protocol design and testing procedures. Neurobehav Toxicol Teratol 7 (1985) 579-586
3. Blumenthal T.D. Short lead interval startle modification. In: Dawson M.E., Schell A.M., and Böhmelt A.H. (Eds). Startle modification: Implications for neuroscience, cognitive science, and clinical science (1999), Cambridge University Press, New York 51-71
4. Blumenthal T.D., and Berg W.K. Stimulus rise time, intensity, and bandwidth effects on acoustic startle amplitude and probability. Psychophysiology 23 (1986) 635-641
5. Braff D.L., Stone C., Callaway E., Geyer M., Glick I., and Bali L. Prestimulus effects of human startle reflex in normals and schizophrenics. Psychophysiology 15 (1978) 339-343
6. Braff D.L., Geyer M.A., Light G.A., Sprock J., Perry W., Cadenhead K.S., et al. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 49 (2001) 171-178
7. Brunell S.C., and Spear L.P. Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats. Psychopharmacology 186 (2006) 579-586
8. Dahmen J.C., and Corr P.J. Prepulse-elicited startle in prepulse inhibition. Biol Psychiatry 55 (2004) 98-101
9. Davis M., Mansbach R.S., Swerdlow N.R., Campeau S., Braff D.L., and Geyer M.A. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology 102 (1990) 1-4
10. Duncan G.E., Moy S.S., Lieberman J.A., and Koller B.H. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 85 (2006) 481-491
11. Gewirtz J.C., and Davis M. Habituation of prepulse inhibition of the startle reflex using an auditory prepulse close to background noise. Behav Neurosci 109 (1995) 388-395
12. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swedlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156 (2001) 117-154
13. Ison J.R. Reflex modification as an objective test for sensory processing following toxicant exposure. Neurobehav Toxicol Teratol 6 (1984) 437-445
14. Jones C.K., and Shannon H.E. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex. J Pharmacol Exp Ther 294 (2000) 1017-1023
15. Jones C.K., and Shannon H.E. Effects of scopolamine in comparison with apomorphine and phencyclidine on prepulse inhibition in rats. Eur J Pharmacol 391 (2000) 105-112
16. Mansbach R.S., and Geyer M.A. Parametric determinants in pre-stimulus modification of acoustic startle: interaction with Ketamine. Psychopharmacology 105 (1991) 162-168
17. Moy S.S., Perez A., Koller B.H., and Duncan G.E. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res 1089 (2006) 186-194
18. Stanhope K.J., Mirza N.R., Bikerdike M.J., Bright J.L., Harrington N.R., Hesselink M.B., et al. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. J Pharmacol Exp Ther 299 (2001) 782-792
19. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., and Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's Disease. J Neurol Neurosurg Psychiatry 58 (1995) 192-200
20. Ukai M., Okuda A., and Mamiya T. Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice. Eur J Pharmacol 492 (2004) 183-187
21. USEPA. Health effects test guidelines, developmental neurotoxicity study, OPPTS 870.6300 (1998)
22. Wu M., Jenden D.J., Fairchild M.D., and Siegel J.M. Cholinergic mechanisms in startle and prepulse inhibition effects of the false cholinergic precursor N-aminodeanol. Behav Neurosci 107 (1993) 306-316
23. Yee B.K., Russig H., and Feldon J. Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity. Neuropsychopharmacology 29 (2004) 240-248